"Nitro Compounds" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds having the nitro group, -NO2, attached to carbon. When attached to nitrogen they are nitramines and attached to oxygen they are NITRATES.
| Descriptor ID |
D009574
|
| MeSH Number(s) |
D02.640
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nitro Compounds".
Below are MeSH descriptors whose meaning is more specific than "Nitro Compounds".
This graph shows the total number of publications written about "Nitro Compounds" by people in this website by year, and whether "Nitro Compounds" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 1 | 0 | 1 |
| 2017 | 4 | 2 | 6 |
| 2018 | 3 | 2 | 5 |
| 2019 | 2 | 1 | 3 |
| 2020 | 0 | 2 | 2 |
| 2021 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Nitro Compounds" by people in Profiles.
-
Early use of nitazoxanide in mild COVID-19 disease: randomised, placebo-controlled trial. Eur Respir J. 2021 07; 58(1).
-
Available drugs and supplements for rapid deployment for treatment of COVID-19. J Mol Cell Biol. 2021 07 06; 13(3):232-236.
-
Role of nitazoxanide as a repurposed drug in the treatment and management of various diseases. Drugs Today (Barc). 2021 Jul; 57(7):455-473.
-
Interventions in an Ambulatory Setting to Prevent Progression to Severe Disease in Patients With COVID-19: A Systematic Review. Ann Pharmacother. 2022 03; 56(3):309-318.
-
NSAIDs/nitazoxanide/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects. Expert Rev Anti Infect Ther. 2022 01; 20(1):17-21.
-
Development of a High-Throughput Screening Assay to Identify Inhibitors of the SARS-CoV-2 Guanine-N7-Methyltransferase Using RapidFire Mass Spectrometry. SLAS Discov. 2021 07; 26(6):749-756.
-
Effect of a combination of nitazoxanide, ribavirin, and ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID-19. J Med Virol. 2021 05; 93(5):3176-3183.
-
Antiviral treatment in COVID-19: which is the most promising?-a narrative review. Ann Palliat Med. 2021 Jan; 10(1):707-720.
-
Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Jan 04; 22(1):3.
-
[2020: Evidence-Based Medicine odyssey. The fall and rise of evidence-based medicine in the year of coronavirus.] Recenti Prog Med. 2021 01; 112(1):15-18.